Financing channel feed – Endpoints News

Financing channel feed

Carbon Biosciences emerges with a new viral vector to shake up the cystic fibrosis gene therapy field

3 years ago

Pfizer nabs $95M stake in Valneva as Lyme disease vaccine approaches pivotal study

3 years ago

In attempted bear market brushback, SMA player Scholar Rock nabs $205M raise on open-label extension data

3 years ago

SPAC deal touches down for microcap biotech armed with a PhII, former Pfizer monoclonal antibody

3 years ago

NASH-focused Akero Therapeutics extends its runway by another year with Pfizer's help

3 years ago

Amidst large investment from parent company, Samsung Biologics seeks to ramp up biotech funding

3 years ago

Spanish PM: Moderna to invest $523M into the country to boost vaccine production

3 years ago

Two days after showing strong pediatric cancer data, Day One taps $150M in public capital

3 years ago

Long-time healthcare investor looks to double number of life sciences startups in its 'evergreen' fund

3 years ago

Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital

3 years ago

Boston startup looks to make a big manufacturing push with new funding round

3 years ago

Following bispecific deal with Pfizer, quiet California biotech raises $65M, heads to the clinic

3 years ago

SPAC merger called off as company connected to ex-Purdue CEO decides to remain private

3 years ago

Zymeworks adds a classic poison pill defense to the armory as the biotech's board battles hostile takeover

3 years ago

A biotech upstart just scored $103M from Pfizer et al to fuel its pursuit of a new (to you) I/O pathway

3 years ago

Psychedelics startup Eleusis axes SPAC deal, but CEO confident its IV psilocybin therapy will enter clinic next month

3 years ago

#BIO22: The bear market may be mauling biotech stocks, but the fundamentals still look good to real estate developers

3 years ago

#BIO22: Are biotech buyouts finally coming into vogue? Here's what to look for in H2 M&A

3 years ago

Senti Bio completes its SPAC merger, though not before seeing investors 'playing a financial game'

3 years ago

During tepid public market, Biospring closes quarter billion dollar manufacturing and tech-focused fund

3 years ago

Exclusive: After Amgen exit, father-son duo gets Lightspeed backing to fund remaining Teneobio 'babies'

3 years ago

Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D

3 years ago

Armed with library of molecular glues, Degron launches out of a Shanghai lab

3 years ago

With deep ties to Baylor and fresh support from Polaris, Singapore's Tessa raises $126M for pivotal CAR study

3 years ago

First page Previous page 53 54 555657 58 59 Next page Last page